Compare Dr. Reddys with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs J.B.CHEMICALS - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB J.B.CHEMICALS DR. REDDYS LAB/
J.B.CHEMICALS
 
P/E (TTM) x 32.2 21.4 151.0% View Chart
P/BV x 3.8 3.0 127.7% View Chart
Dividend Yield % 0.6 0.4 157.3%  

Financials

 DR. REDDYS LAB   J.B.CHEMICALS
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
J.B.CHEMICALS
Mar-18
DR. REDDYS LAB/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs2,875363 791.8%   
Low Rs1,888255 740.4%   
Sales per share (Unadj.) Rs930.2169.1 550.0%  
Earnings per share (Unadj.) Rs117.416.6 707.4%  
Cash flow per share (Unadj.) Rs185.823.4 793.3%  
Dividends per share (Unadj.) Rs20.002.00 1,000.0%  
Dividend yield (eoy) %0.80.6 129.8%  
Book value per share (Unadj.) Rs844.4172.5 489.5%  
Shares outstanding (eoy) m166.0783.57 198.7%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x2.61.8 140.1%   
Avg P/E ratio x20.318.6 108.9%  
P/CF ratio (eoy) x12.813.2 97.1%  
Price / Book Value ratio x2.81.8 157.4%  
Dividend payout %17.012.0 141.4%   
Avg Mkt Cap Rs m395,49625,827 1,531.3%   
No. of employees `00022.03.8 582.3%   
Total wages/salary Rs m33,5622,511 1,336.6%   
Avg. sales/employee Rs Th7,032.83,747.4 187.7%   
Avg. wages/employee Rs Th1,527.9665.7 229.5%   
Avg. net profit/employee Rs Th887.7367.8 241.4%   
INCOME DATA
Net Sales Rs m154,48214,135 1,092.9%  
Other income Rs m3,375366 922.6%   
Total revenues Rs m157,85714,501 1,088.6%   
Gross profit Rs m31,7822,178 1,459.0%  
Depreciation Rs m11,348570 1,991.9%   
Interest Rs m88935 2,547.3%   
Profit before tax Rs m22,9201,940 1,181.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,858552 698.5%   
Profit after tax Rs m19,5001,387 1,405.7%  
Gross profit margin %20.615.4 133.5%  
Effective tax rate %16.828.5 59.1%   
Net profit margin %12.69.8 128.6%  
BALANCE SHEET DATA
Current assets Rs m111,10110,470 1,061.1%   
Current liabilities Rs m58,9732,749 2,145.3%   
Net working cap to sales %33.754.6 61.8%  
Current ratio x1.93.8 49.5%  
Inventory Days Days7955 143.8%  
Debtors Days Days9478 121.3%  
Net fixed assets Rs m101,2455,811 1,742.3%   
Share capital Rs m830167 496.7%   
"Free" reserves Rs m139,40614,248 978.4%   
Net worth Rs m140,23614,416 972.8%   
Long term debt Rs m22,0000-   
Total assets Rs m224,65617,649 1,272.9%  
Interest coverage x26.856.6 47.3%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.70.8 85.9%   
Return on assets %9.18.1 112.6%  
Return on equity %13.99.6 144.5%  
Return on capital %14.913.7 109.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m88,6736,164 1,438.6%   
Fx outflow Rs m19,1041,334 1,431.6%   
Net fx Rs m69,5694,829 1,440.5%   
CASH FLOW
From Operations Rs m28,7041,231 2,332.7%  
From Investments Rs m-7,727-208 3,713.1%  
From Financial Activity Rs m-21,326-595 3,583.0%  
Net Cashflow Rs m-314427 -73.5%  

Share Holding

Indian Promoters % 25.5 55.4 46.0%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 5.4 3.4 159.3%  
FIIs % 35.3 3.9 905.1%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 37.0 41.4%  
Shareholders   75,885 30,437 249.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   TTK HEALTHCARE  SUVEN LIFESCIENCES  STERLING BIOTECH  ELDER PHARMA  ALEMBIC LTD  

Compare DR. REDDYS LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 188 Points Lower; Metal and Telecom Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day on a negative note. At the closing bell, the BSE Sensex stood lower by 188 points (down 0.5%).

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

How to Buy the Best Safe Stocks in 2020(The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market(Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

The Best Asset Class to Invest in 2020(Fast Profits Daily)

Jan 24, 2020

Why I'm most bullish on this asset class above all else in 2020.

What the Infosys Results Tell Us About the Next Infosys(The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jan 28, 2020 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS